The "Dual Catalog" of medical insurance and commercial insurance has been released, with products from multiple innovative pharmaceutical companies making the list

Wallstreetcn
2025.12.08 22:12

Recently, the National Healthcare Security Administration and the Ministry of Human Resources and Social Security issued the "National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog" and the first edition of the "Commercial Health Insurance Innovative Drug Catalog." The new version of the dual catalog for commercial insurance will be officially implemented nationwide starting January 1, 2026. From December 7 to 8, several listed companies, including Hengrui Pharma, FOSUN PHARMA, Hisun Pharmaceutical, Beihai Kangcheng, and Junshi Biosciences, announced new drug entries, renewals, or new indications included in the new national medical insurance catalog and the first edition of the commercial insurance innovative drug catalog. (Shanghai Securities Journal)

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer